These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 6221798

  • 1. Treatment of lower respiratory tract infections with cefoperazone.
    Kaplowitz LG, Sarubbi FA.
    Clin Ther; 1983; 5(3):243-50. PubMed ID: 6221798
    [Abstract] [Full Text] [Related]

  • 2. Clinical trials with cefoperazone in the field of internal medicine in Japan.
    Mashimo K, Kunii O.
    Clin Ther; 1980; 3(Spec Issue):159-72. PubMed ID: 6446392
    [Abstract] [Full Text] [Related]

  • 3. [Netilmicin in the treatment of bacterial respiratory tract infections].
    Wandzilak M, Głuszko P, Królikowski W, Prokop A, Soja J, Szczeklik A.
    Pol Tyg Lek; 1980; 45(36-37):749-51. PubMed ID: 2084631
    [Abstract] [Full Text] [Related]

  • 4. [The French experience with moxalactam in pneumology].
    Leng B, Imbert Y, Coomans D.
    Sem Hop; 1983 Jun 30; 59(26):1977-80. PubMed ID: 6310790
    [Abstract] [Full Text] [Related]

  • 5. Position of ceftazidime in respiratory diseases.
    Ando' F, Girbino G, Ferrara F.
    Drugs Exp Clin Res; 1985 Jun 30; 11(6):369-72. PubMed ID: 3915288
    [Abstract] [Full Text] [Related]

  • 6. Asian multicenter trial of cefoperazone in respiratory tract infection.
    Matsumoto K, Chung HY, Hsieh WC.
    Clin Ther; 1984 Jun 30; 6(6):824-38. PubMed ID: 6391668
    [Abstract] [Full Text] [Related]

  • 7. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS, Ramirez-Ronda C, Saavedra S, Rivera-Vázquez CR, Liu C, Hinthorn DR.
    Clin Ther; 1993 Jun 30; 15(1):65-78. PubMed ID: 8458056
    [Abstract] [Full Text] [Related]

  • 8. Cefoperazone therapy of serious infections.
    Temple J, Mogabgab WJ.
    Clin Ther; 1982 Jun 30; 4(6):450-64. PubMed ID: 6212120
    [Abstract] [Full Text] [Related]

  • 9. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF, Palombini BC, Dagrosa EE, Mendoza F, Facco EB.
    Arzneimittelforschung; 1997 May 30; 47(5):674-7. PubMed ID: 9205786
    [Abstract] [Full Text] [Related]

  • 10. Clinical and laboratory evaluation of cefoperazone.
    Sarver DK, Christensen GD, Hester MG, Ling FW, Pate JW, Rosenberg EW, Anderson GD, Bisno AL.
    Clin Ther; 1981 May 30; 4(3):164-74. PubMed ID: 6458360
    [Abstract] [Full Text] [Related]

  • 11. [Clinical study of 25 patients treated with cefoperazone, a 3d generation cephalosporin].
    Clément M, Regamey C.
    Rev Med Suisse Romande; 1982 Sep 30; 102(9):833-8. PubMed ID: 6216572
    [No Abstract] [Full Text] [Related]

  • 12. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO, Ohaju-Obodo J.
    West Afr J Med; 1996 Sep 30; 15(2):111-6. PubMed ID: 8855675
    [Abstract] [Full Text] [Related]

  • 13. Treatment of lower respiratory tract infections with sultamicillin.
    Tageldin MA, Said A.
    J Int Med Res; 1992 Sep 30; 20 Suppl 1():44A-52A. PubMed ID: 1451929
    [Abstract] [Full Text] [Related]

  • 14. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984 Sep 30; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 15. Multicentered clinical evaluation of cefoperazone for the treatment of lower respiratory tract infections.
    Gardner WG.
    Rev Infect Dis; 1983 Sep 30; 5 Suppl 1():S137-44. PubMed ID: 6221383
    [Abstract] [Full Text] [Related]

  • 16. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J, Sauvaget J.
    Nouv Presse Med; 1981 Feb 26; 10(8):650-3. PubMed ID: 6259612
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Matsuba K, Yoshida M, Ichikawa Y, Ando M, Matsuzaki Y, Kitahara Y, Hara N.
    Jpn J Antibiot; 1986 Oct 26; 39(10):2780-94. PubMed ID: 3543433
    [Abstract] [Full Text] [Related]

  • 18. [Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
    Jendroschek T, Belmega G, Lode H, Kemmerich B, Dzwillo G, Koeppe P, Wagner J.
    Med Klin; 1981 Feb 13; 76(4):102-6, 70. PubMed ID: 6452567
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun 13; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 20. [Cefoperazone--Possibility of safer treatment for infections in patients with chronic renal failure].
    Klinger M, Szewczyk Z, Kazimierczak K, Kramarz S.
    Wiad Lek; 1995 Jun 13; 43(15-16):773-6. PubMed ID: 2275197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.